Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06174272
Other study ID # STUDY00023071
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date March 1, 2026

Study information

Verified date April 2024
Source Milton S. Hershey Medical Center
Contact Alison J Faust, MD
Phone 7175311017
Email afaust1@pennstatehealth.psu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital. The main question[s] it aims to answer are: - How much time and what resources are needed to run such a program - How well do patients follow up with the phone calls, bloodwork, and doctor appointments? - Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program? Participants will - Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital - Receive a phone call from the study team within 72 hours of discharge and weekly - Be given a follow up appointment with hepatology within 4 weeks of discharge Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date March 1, 2026
Est. primary completion date March 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients > 18 years of age. - Inpatient at Penn State Health, Milton S. Hershey Medical Center. - Diagnosis of cirrhosis. - Hospitalized with fluid overload (ascites and/or significant anasarca/edema) requiring diuretic therapy. - English speaking Exclusion Criteria: - Placement of a TIPS. - Ascites from an etiology other than cirrhosis, such as malignancy, heart failure, pancreatitis, nephrotic syndrome. - Non-English speaking

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Transitional Care Program
Intensive monitoring post discharge for cirrhosis and fluid overload

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Milton S. Hershey Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary feasibility of the program how much time does it take to review material and complete phone calls all 8 weeks of each participant
Primary Number of instances of weight monitoring at home monitoring weight 8 weeks for each participant
Primary Number of successful phone calls weekly phone call with participant 8 weeks for each participant
Primary Number of follow up visits lab visits, primary care visits, hepatology visits 8 weeks for each participant
Secondary Number of Hospitalizations per participant number of admissions to the hospital 12 months
Secondary Number of subjects that develop Acute Kidney Injury Creatinine increase of >0.3g/dL 12 months
Secondary Number of subjects that continue to have volume overload persistent weight above dry weight and/or ongoing ascites/lower extremity edema/pleural effusion 12 months
Secondary Number of subjects that expire subject death 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05793983 - S100A8/A9 and Innate Immunity in Liver Disease
Completed NCT04604860 - Use of EL-FIT App to Promote Physical Activity N/A
Recruiting NCT05928624 - A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients N/A
Active, not recruiting NCT01438970 - Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function Phase 2
Recruiting NCT05998330 - LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease N/A
Completed NCT04581369 - Cirrhosis Medical Home N/A
Withdrawn NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Recruiting NCT04588077 - Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis Phase 4
Recruiting NCT05538962 - Longitudinal Monitoring of Inflammation in Cirrhosis N/A
Completed NCT04082780 - Rifamycin in Minimal Hepatic Encephalopathy Phase 2
Completed NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Active, not recruiting NCT03736265 - Carvedilol for Prevention of Esophageal Varices Progression N/A
Recruiting NCT04530760 - Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical Ventilation
Recruiting NCT05093218 - Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease. N/A
Recruiting NCT03437876 - Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis N/A
Recruiting NCT05604274 - Longitudinal Monitoring of Stool Characteristics
Recruiting NCT04867954 - Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Completed NCT04643795 - Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects Phase 1
Active, not recruiting NCT02344680 - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Completed NCT04121520 - Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey